Nuzenio

Aquestive Therapeutics

Aquestive Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Aquestive Therapeutics (NASDAQ:AQST): What Could Today’s Update Reveal About Regulatory Progress And Commercial Preparation? - Kalkine MediaKalkine Media · Tue, 11 Aug 2026 09:37:00 GMTAquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study - TradingViewTradingView · Mon, 10 Aug 2026 18:06:36 GMTAnaphylm sublingual epinephrine film shows improved usability, comparable PK ahead of planned FDA resubmission - Contemporary PediatricsContemporary Pediatrics · Mon, 10 Aug 2026 14:44:47 GMTAquestive Therapeutics shares jump after encouraging Anaphylm study results - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 14:24:58 GMTEarnings To Watch: Aquestive Therapeutics Inc (AQST) Q2 2026 -- GF Value Sees 35% Downside - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:20:01 GMTAquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film - Investing News NetworkInvesting News Network · Mon, 10 Aug 2026 12:54:11 GMTAquestive Therapeutics releases Anaphylm human factors, clinical study presentation materials - BitgetBitget · Mon, 10 Aug 2026 11:58:07 GMTAquestive Reports Positive Human Factors and PK Results for Anaphylm, Plans NDA Resubmission Q3 2026 - TradingViewTradingView · Mon, 10 Aug 2026 11:13:01 GMT

Timeline

Tue, 11 Aug 2026 09:37:00 GMTAquestive Therapeutics (NASDAQ:AQST): What Could Today’s Update Reveal About Regulatory Progress And Commercial Preparation? - Kalkine Media
Mon, 10 Aug 2026 18:06:36 GMTAquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study - TradingView
Mon, 10 Aug 2026 14:44:47 GMTAnaphylm sublingual epinephrine film shows improved usability, comparable PK ahead of planned FDA resubmission - Contemporary Pediatrics
Mon, 10 Aug 2026 14:24:58 GMTAquestive Therapeutics shares jump after encouraging Anaphylm study results - Yahoo Finance
Mon, 10 Aug 2026 13:20:01 GMTEarnings To Watch: Aquestive Therapeutics Inc (AQST) Q2 2026 -- GF Value Sees 35% Downside - Yahoo Finance
Mon, 10 Aug 2026 12:54:11 GMTAquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film - Investing News Network

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aquestive Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.